New York Lawmaker Files Cannabis Community Reinvestment Act, Requiring Marijuana Businesses to Invest in Communities Impacted by Prohibition

New York State Assemblymember Stefani Zinerman (D) introduced Assembly Bill 5647 today, known as the Cannabis Community Reinvestment Act.

The bill would require marijuana businesses in the state to allocate a portion of their revenue to support communities disproportionately impacted by past prohibition policies.

Under the proposed legislation, licensed cannabis operators would be required to contribute at least 2% of their annual profits to community reinvestment efforts. Each operator would need to submit a reinvestment plan outlining how they intend to support affected communities, including, if applicable, the area where their business is located. The New York State Cannabis Control Board would oversee compliance, establishing criteria and a scoring system for evaluating these plans.
Continue reading

Tennessee Bill to Legalize Medical Cannabis Scheduled for Consideration in Senate Judiciary Committee on February 25

Tennessee’s Senate Bill 489, known as the Medical Cannabis Act, is scheduled to be discussed and potentially receive a vote in its committee of origin on February 25.

Sponsored by State Senator Janice Bowling (R) and filed on January 29, SB 489 has been scheduled for consideration in the Senate Judiciary Committee during their February 25 meeting that begins at 3pm CST. The committee’s placement on the calendar means that it will be discussed by members, and potentially receive a vote.

If enacted, the bill would legalize the possession, use and licensed distribution of medical cannabis, with rules and licensing handled by a newly-created Medical Cannabis Program Commission. This would make Tennessee the 40th medical marijuana state.
Continue reading

Oklahoma Senate Public Safety Committee Unanimously Approves Bill on Gun Rights for Medical Marijuana Patients

A key committee in the Oklahoma Senate gave unanimous approval today to legislation that would establish gun right protections for medical cannabis patients.

Oklahoma Senate Bill 39 was unanimously approved by the Senate Public Safety Committee today in a 6 to 0 vote. The bill, introduced by State Senator Julie Daniels, prohibits individuals from being automatically disqualified from obtaining a handgun license solely based on their status as a medical cannabis patient.

SB 39 also modifies existing firearm laws by adding medical marijuana to the list of substances under which carrying a firearm is prohibited if the substance impairs mental, emotional, or physical faculties. However, it explicitly states that possessing a valid medical marijuana patient license cannot be used as grounds to deny an individual’s eligibility for a handgun license.
Continue reading

Virginia Legislature Approves Bill Updating Medical Marijuana Labeling and Expanding Home Delivery

The Virginia Senate has approved House Bill 1989, a measure updating medical marijuana product labeling requirements and expanding delivery options for registered patients.

The bill passed the Senate today in a 30 to 10 vote. Given it was amended slightly in the Senate, the measure will now return to the House of Delegates for a final concurrence vote before heading to the governor’s desk.

Sponsored by Delegate Alex Askew (D), the legislation updates labeling rules for medical marijuana products, requiring pharmaceutical processors to provide clearer cannabinoid content information. Specifically, labels would need to display:

Continue reading

Doctors and Researchers File Court Petition Challenging DEA’s Marijuana Rescheduling Process

A coalition of doctors and researchers advocating for marijuana rescheduling has petitioned a federal court to intervene in what they argue is a secretive and biased process led by the U.S. Drug Enforcement Administration (DEA).

The group, known as Doctors for Drug Policy Reform (DDPR), filed its petition Monday in the U.S. Court of Appeals for the D.C. Circuit, seeking to force the DEA to revise key steps in its handling of marijuana’s classification under federal law.

Led by Dr. Bryon Adinoff, a clinical researcher and professor of psychiatry at the University of Colorado School of Medicine, DDPR contends that the DEA’s decision-making has excluded key stakeholders without justification. The group was among 138 parties denied the opportunity to participate in an administrative hearing regarding the potential move of marijuana from Schedule I to Schedule III of the Controlled Substances Act.

Continue reading

Wisconsin Governor Includes Marijuana Legalization in 2025-2027 Budget as Bicameral Bills Are Filed

Wisconsin Governor Tony Evers has included a proposal to legalize marijuana in his 2025-2027 budget request, marking another push to regulate and tax cannabis similar to alcohol.

On the same day, bipartisan legislation—Assembly Bill 50 and Senate Bill 45—was introduced in the state legislature to legalize and regulate marijuana for adult use.

“Legalize, regulate, and tax the sale of marijuana for recreational use, much like Wisconsin already does with alcohol,” said Governor Evers’ office The proposal estimates $58.1 million in revenue for fiscal year 2026-27, with increasing amounts expected in subsequent years.
Continue reading

Nebraska Bill to Restrict Medical Marijuana to Pills and Tinctures Scheduled for Public Hearing

A Nebraska measure that would significantly restrict the allowable forms of medical cannabis has been scheduled for a public hearing in the General Affairs Committee.

Marijuana capsules.

Filed by Senator Storm last month, the proposal would limit medical marijuana products to pills and liquid tinctures, excluding other forms such as edibles, concentrates, and smokable products. The hearing has been scheduled for 1:30pm on March 3 in Room 1023.

This proposal comes in the wake of the Nebraska Medical Cannabis Patient Protection Act (Initiative 437) and the Nebraska Medical Cannabis Regulation Act (Initiative 438), which both became law in December. These initiatives established legal protections for patients and healthcare providers, allowed patients to possess up to five ounces of marijuana with a physician’s recommendation, and set the framework for a regulated medical marijuana market.
Continue reading

Oregon Initiative Would Legalize Cannabis Cafes, Proponents Aim for November 2026 Ballot

A proposed initiative in Oregon would legalize cannabis cafes, allowing licensed venues to serve food and drinks while permitting on-site marijuana consumption.

Backed by the Oregon Cannabis Cafe Coalition, the initiative would amend existing state law to introduce regulated smoking lounges and, eventually, cafes offering infused edibles.

“The Cannabis Cafe Coalition is dedicated to making amendments to bill 475C.097 (Cannabis Retail Sales & Licensing)”, states the group on their website. “The goal is to create a bill that will allow regulated smoking lounges and eventually infused edible cafes in the city of Portland.”
Continue reading

Verano Announces Opening of Medical Cannabis Dispensary in North Miami Beach, Company’s 80th Florida Location, 153rd Nationwide

Verano Holdings Corp., a leading multi-state cannabis company, today announced the opening of MÜV North Miami Beach on Friday, February 21st, the company’s 80th Florida location.

The new location, located at 16635 NE 19th Ave, will be open from Monday to Saturday from 9 a.m. to 7 p.m. and Sunday from 11 a.m. to 5 p.m. local time. Once open, Verano will have 153 dispensaries operating across over a dozen states.

Located in Florida’s Miami-Dade County, the state’s largest county by population with over 2.6 million residents, MÜV North Miami Beach sits in a prime location just west of Biscayne boulevard on 19th Avenue, a bustling thoroughfare with a daily traffic count of 25,000 vehicles2. The dispensary marks a milestone as Verano’s 80th location in the Sunshine State and fourth in Miami-Dade County, complementing existing locations in North Miami – Biscayne, MÜV Miami – Kendall, and MÜV Naranja. MÜV North Miami Beach is conveniently located next to Miami’s Snake Creek Canal and a short trip from area beaches, shopping areas and other favorite attractions popular with locals, tourists and seasonal residents alike.
Continue reading

THCV and CBD Mucoadhesive Strips Linked to Weight Loss and Metabolic Benefits, Study Finds

A new placebo-controlled study found that mucoadhesive strips containing tetrahydrocannabivarin (THCV) and cannabidiol (CBD) led to significant weight loss and metabolic improvements over 90 days.

The study involved 44 participants, including 31 women and 13 men, with an average age of 51.75 years. Researchers tested two different doses: 8 mg THCV/10 mg CBD and 16 mg THCV/20 mg CBD, taken once daily. Participants were monitored for changes in weight, abdominal girth, systolic blood pressure, and cholesterol levels.

Both dosage levels resulted in statistically significant weight loss, reductions in waist circumference, lower systolic blood pressure, and decreased LDL cholesterol compared to the placebo group. The higher dose demonstrated a greater effect on weight loss. Researchers noted that these findings align with prior unpublished studies involving THCV-rich hemp extracts.
Continue reading